12P Atezolizumab plus bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance: Final results from the randomised, non-comparative phase II ETOP ABC-lung trial M. Frueh, R.A. Soo, A. Vervita,B.C. Cho, M. Majem,D. Rodriguez Abreu, A. Callejo Perez,M.T. Moran Bueno,M. Domine Gomez,M. Provencio Pulla, A. Addeo,J-Y. Han, A.L.O. Ortega Granados, K. Ribi, H. Roschitzki-Voser, B. Ruepp, M. Haberecker, U. Dafni, S. Peters, R.A. StahelESMO Open（2024）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
